[Psoriasis und Psoriasis arthritis in childhood and adolescence. Overview and consensus statement of the 9th Wörlitz Expert Round Table Discussion 2006 for the Society for Child and Adolescent Rheumatology]
- PMID: 17623119
- DOI: 10.1007/s00393-007-0145-9
[Psoriasis und Psoriasis arthritis in childhood and adolescence. Overview and consensus statement of the 9th Wörlitz Expert Round Table Discussion 2006 for the Society for Child and Adolescent Rheumatology]
Abstract
There are about 1.2-1.6 million psoriasis sufferers in Germany. In about a third of these, the disease manifests before the age of 20. A classic complication of psoriasis is psoriasis arthritis (PsA), which, from the latest figures, effects about 20% of all psoriasis patients. PsA also starts in childhood and is included under the term juvenile idiopathic arthritis (JIA). The expert round table discussion which took place in 2006 in Wörlitz elaborated the recommendations for the classification, comprehensive diagnostics and therapy of effected children and adolescents. As controlled studies are lacking, the treatment of PsA has been empirically based and carried out in analogy with the treatment of other forms of JIA. The use of methotrexate (MTX) shows a good success rate. In 2004, about a third of the patients found in the core documentation, including over 80% of children and adolescents undergoing a primary therapy, were treated with MTX, a quarter in combination with other medication. A total of 7% of all and 16% of those undergoing primary therapy were treated with etanercept, most (>80%) in combination with basis medication, usually MTX. Consensus opinion indicated that an early, and intensive local skin therapy should be applied in order to reduce inflammatory activity. If PsA is present, the early use of non-steroid anti-inflammatories as well as local therapy of the joints with the intra-articular application of glucocorticosteroids is recommended. The primary medication should preferentially be MTX, if necessary combined with other therapies. In cases of a severe, episodic progression as well as high inflammatory activity, systemic glucocorticosteroids should be considered. Further studies addressing both the clinical course of jPsA compared to the adult manifestation as well as optimal therapeutic procedures should be initiated in the near future.
Similar articles
-
Treatment of psoriatic arthritis: management recommendations.Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S73-7. Epub 2015 Oct 15. Clin Exp Rheumatol. 2015. PMID: 26471459 Review.
-
Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.Curr Rheumatol Rep. 2017 Nov 20;20(1):1. doi: 10.1007/s11926-017-0706-0. Curr Rheumatol Rep. 2017. PMID: 29185062 Review.
-
[Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].Z Rheumatol. 2004 Apr;63(2):147-58. doi: 10.1007/s00393-004-0534-2. Z Rheumatol. 2004. PMID: 15112095 Review. German.
-
Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.J Rheumatol. 2017 May;44(5):693-694. doi: 10.3899/jrheum.170148. J Rheumatol. 2017. PMID: 28461529
-
Addressing comorbidities in psoriatic disease.Rheumatol Int. 2018 Feb;38(2):219-227. doi: 10.1007/s00296-017-3895-y. Epub 2017 Nov 28. Rheumatol Int. 2018. PMID: 29185085
Cited by
-
[Children and adolescents with psoriasis. What therapy is recommended?].Hautarzt. 2012 Mar;63(3):192-201. doi: 10.1007/s00105-011-2229-3. Hautarzt. 2012. PMID: 22382304 Review. German.
-
Safety and efficacy of etanercept in children with the JIA categories extended oligoarthritis, enthesitis-related arthritis and psoriasis arthritis.Clin Rheumatol. 2015 Jan;34(1):61-9. doi: 10.1007/s10067-014-2744-6. Epub 2014 Jul 18. Clin Rheumatol. 2015. PMID: 25034081
-
Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.Paediatr Drugs. 2015 Oct;17(5):373-84. doi: 10.1007/s40272-015-0137-1. Paediatr Drugs. 2015. PMID: 26072040 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous